Stockscreener 앱 받기
12.85
3.17%
-0.42
시장 영업 전:
12.81
-0.04
-0.31%
전일 마감가:
$13.27
열려 있는:
$13.4
하루 거래량:
331.72K
Relative Volume:
2.32
시가총액:
$80.23M
수익:
-
순이익/손실:
$-14.56M
주가수익비율:
-0.764
EPS:
-16.82
순현금흐름:
$-12.46M
1주 성능:
+5.41%
1개월 성능:
+33.16%
6개월 성능:
+123.48%
1년 성능:
+100.47%
1일 변동 폭
$12.40
$14.02
1주일 범위
$10.94
$14.02
52주 변동 폭
$4.63
$14.22
Tenax Therapeutics Inc Stock (TENX) Company Profile
명칭
Tenax Therapeutics Inc
전화
919-855-2100
주소
101 GLEN LENNOX DRIVE, CHAPEL HILL, NC
TENX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TENX
Tenax Therapeutics Inc
|
12.85 | 82.85M | 0 | -14.56M | -12.46M | -16.82 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.15 | 118.84B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
812.27 | 81.61B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
422.50 | 53.69B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
822.94 | 49.49B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
176.00 | 37.34B | 447.02M | -1.18B | -906.14M | -6.1812 |
Tenax Therapeutics Inc Stock (TENX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-08 | 개시 | Piper Sandler | Overweight |
| 2024-10-24 | 개시 | Leerink Partners | Outperform |
| 2024-10-14 | 개시 | Guggenheim | Buy |
| 2024-09-30 | 개시 | William Blair | Outperform |
| 2017-05-18 | 업그레이드 | Ladenburg Thalmann | Neutral → Buy |
| 2014-12-16 | 개시 | MLV & Co | Buy |
| 2014-11-18 | 개시 | WallachBeth | Buy |
모두보기
Tenax Therapeutics Inc 주식(TENX)의 최신 뉴스
Precision Trading with Tenax Therapeutics Inc. (TENX) Risk Zones - Stock Traders Daily
Tenax Therapeutics: How Lower Variance In Phase 3 Has "Loaded The Dice" For An Asymmetric Repricing - Seeking Alpha
Tenax Therapeutics (NASDAQ:TENX) Stock Price Crosses Above 200 Day Moving AverageHere's Why - MarketBeat
Tenax Therapeutics Inc. (TENX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
How Tenax Therapeutics Inc. (TENX) Affects Rotational Strategy Timing - Stock Traders Daily
Tenax Therapeutics (NASDAQ:TENX) Stock Crosses Above 200-Day Moving AverageHere's What Happened - MarketBeat
Tenax Therapeutics (TENX) Price Target Increased by 12.22% to 25.76 - Nasdaq
Will Tenax Therapeutics Inc. stock see insider buying2025 Trading Recap & Verified High Yield Trade Plans - DonanımHaber
Is Tenax Therapeutics Inc. stock near bottom after declineWeekly Trade Report & Safe Capital Growth Tips - DonanımHaber
Is Tenax Therapeutics Inc. stock overvalued by current metricsJuly 2025 Spike Watch & Fast Exit and Entry Strategy Plans - DonanımHaber
Roth MKM Reaffirms Their Buy Rating on Tenax Therapeutics (TENX) - The Globe and Mail
Is Tenax Therapeutics Inc. stock supported by strong cash flowsMarket Movers & Low Drawdown Investment Ideas - DonanımHaber
Tenax Therapeutics (NASDAQ:TENX) Stock Crosses Above 200 Day Moving Average – What’s Next? - Defense World
Can Tenax Therapeutics Inc. stock beat market expectations this quarter2025 Technical Patterns & Safe Capital Growth Stock Tips - Улправда
Tenax Therapeutics (NASDAQ:TENX) Stock Crosses Above 200 Day Moving AverageWhat's Next? - MarketBeat
Guggenheim Maintains Tenax Therapeutics (TENX) Buy Recommendation - Nasdaq
Tenax Therapeutics’ phase 3 LEVEL study confirms enrollment target By Investing.com - Investing.com Canada
[8-K] TENAX THERAPEUTICS, INC. Reports Material Event | TENX SEC FilingForm 8-K - Stock Titan
Tenax Therapeutics (TENX) Updates on Clinical Trials and New Ini - GuruFocus
Tenax Therapeutics’ phase 3 LEVEL study confirms enrollment target - Investing.com
Tenax Therapeutics level trial on track to complete enrollment in H1 2026 - marketscreener.com
Tenax Therapeutics Confirms Enrollment Target for LEVEL Study; Initiates LEVEL-2 Phase 3 Study for TNX-103 - Quiver Quantitative
Tenax Therapeutics Level Trial On Track To Complete Enrollment In H1 2026 - TradingView — Track All Markets
Tenax Therapeutics Announces Result of Prespecifed Blinded Sample Size Assessment - The Manila Times
Heart failure drug trials expand as Tenax starts second Phase 3 study - Stock Titan
Tenax Therapeutics stock price target raised to $25 from $14 at Guggenheim - Investing.com Canada
Tenax Therapeutics (TENX): Analyst Raises Target Price to $25 | - GuruFocus
Growth Report: Is YETI stock recession proof2025 Buyback Activity & Safe Entry Zone Tips - moha.gov.vn
Discipline and Rules-Based Execution in TENX Response - Stock Traders Daily
Tenax Therapeutics Earnings Notes - Trefis
What analysts say about Tenax Therapeutics Inc stockCovered Call Writing & Build Winning Strategies With Zero Cost - earlytimes.in
JANUS HENDERSON GROUP PLC Acquires Additional Shares in Tenax Therapeutics Inc - GuruFocus
Tenax Therapeutics (NASDAQ:TENX) Insider Stuart Rich Buys 2,500 Shares - MarketBeat
Tenax Therapeutics director Rich Stuart buys $50,792 in stock By Investing.com - Investing.com South Africa
Tenax Therapeutics director Rich Stuart buys $50,792 in stock - Investing.com
Officer/Dir Rich Buys 5,000 ($50.8K) Of Tenax Therapeutics Inc [TENX] - TradingView — Track All Markets
TENAX Therapeutics CMO Stuart Rich Acquires 5,000 Shares - TradingView — Track All Markets
Tenax Therapeutics (NASDAQ:TENX) Insider Stuart Rich Buys 1,500 Shares - MarketBeat
Officer/Dir Rich Buys 5,000 ($45.6K) Of Tenax Therapeutics Inc [TENX] - TradingView
What technical signals suggest for Tenax Therapeutics Inc. stock2025 Macro Impact & Short-Term High Return Strategies - Newser
Behavioral Patterns of TENX and Institutional Flows - Stock Traders Daily
Why Tenax Therapeutics Inc. stock could benefit from AI revolution2025 Trading Volume Trends & Comprehensive Market Scan Insights - Newser
Financial Analysis: Mainz Biomed (NASDAQ:MYNZ) vs. Tenax Therapeutics (NASDAQ:TENX) - Defense World
Tenax Therapeutics (NASDAQ:TENX) Stock Price Passes Above 200 Day Moving AverageShould You Sell? - MarketBeat
What analysts say about Tenax Therapeutics Inc. stockMean Reversion Trades & Market-Leading Growth Rates - earlytimes.in
Tenax Therapeutics to Participate in Upcoming Investor Conferences - Investing News Network
Tenax Therapeutics (Nasdaq: TENX) plans Dec. 2 and 4 fireside chats at Evercore, Piper - Stock Titan
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
(TENX) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
GIORDANO CHRISTOPHER THOMAS Insider Trades - Nasdaq
Is Tenax Therapeutics Inc. stock a safe buy before earningsEarnings Growth Report & Reliable Volume Spike Trade Alerts - newser.com
Tenax Therapeutics Inc (TENX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
28.63%
자본화:
|
볼륨(24시간):